2,040
Views
6
CrossRef citations to date
0
Altmetric
Editorial

Cardiovascular disease and dementia risk: an ever growing problem in an aging population

&
Pages 771-773 | Received 21 Mar 2016, Accepted 29 Apr 2016, Published online: 13 May 2016

References

  • Kuller LH, Lopez OL, Becker JT, et al. Risk of dementia and death in the long-term follow-up of the Pittsburgh Cardiovascular Health Study-cognition study. Alzheimers Dement 2016;12:170–183.
  • Lopez OL, Klunk WE, Mathis C, et al. Amyloid, neurodegeneration, and small vessel disease as predictors of dementia in the oldest-old. Neurology. 2014;83:1804–1811.
  • Kuller LH, Lopez OL, Jagust WJ, et al. Determinants of vascular dementia in the cardiovascular health cognition study. Neurology. 2005;64:1548–1552.
  • Ighodaro ET, Abner EL, Fardo DW, et al. Risk factors and global cognitive status related to brain arteriolosclerosis in elderly individuals. J Cereb Blood Flow Metab. 2016 doi:10.1177/0271678X15621574. [Epub ahead of print].
  • Snyder HM, Corriveau RA, Craft S, et al. Vascular contributions to cognitive impairment and dementia including Alzheimer’s disease. Alzheimers Dement. 2015;11:710–717.
  • Kuller LH, Lopez OL. Preventing dementia in older cardiovascular patients. Curr Cardiovasc Risk Rep. 2014;8:401–409.
  • Kuller LH, Lopez OL, Mackey RH, et al. Subclinical cardiovascular disease and death, dementia, and coronary heart disease in subjects 80+ years of age. J Am Coll Cardiol. 2016;67;1013–1022.
  • Hughes TM, Kuller LH, Barinas-Mitchell EJ, et al. Pulse wave velocity is associated with beta-amyloid deposition in the brains of very elderly adults. Neurology. 2013;81:1711–1718.
  • Grimmer T, Faust M, Auer F, et al. White matter hyperintensities predict amyloid increase in Alzheimer’s disease. Neurobiol Aging. 2012;33:2766–2773.
  • Jack CR Jr., Therneau TM, Wiste HJ, et al. Transition rates between amyloid and neurodegeneration biomarker states and to dementia: a population-based, longitudinal cohort study. Lancet Neurol. 2016;15:56–64.
  • Stukas S, Robert J, Wellington CL. High-density lipoproteins and cerebrovascular integrity in Alzheimer’s disease. Cell Metab. 2014;19:574–591.
  • Gerber Y, Weston SA, Enriquez-Sarano M, et al. Atherosclerotic burden and heart failure after myocardial infarction. JAMA Cardiol. 2016. Epub 2016 Mar 30. doi:10.1001/jamacardio.2016.0074.
  • Willis MS, Patterson C. Proteotoxicity and cardiac dysfunction--Alzheimer’s disease of the heart? N Engl J Med. 2013;368:455–464.
  • Mohammed SF, Mirzoyev SA, Edwards WD, et al. Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction. J Am Coll Cardiol HF. 2014;2:133–22.
  • Vitali C, Wellington CL, Calabresi L. HDL and cholesterol handling in the brain. Cardiovasc Res. 2014;103:405–413.
  • Ngandu T, Lehtisalo J, Solomon A, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet. 2015;385:2255–2263.
  • Chakradhar S. The road less traveled: start-ups invest in novel approaches against neurodegeneration. Nat Med. 2016;22:11–13.
  • Sagare A, Deane R, Bell RD, et al. Clearance of amyloid-beta by circulating lipoprotein receptors. Nat Med. 2007;13:1029–1031.
  • Hughes TM, Craft S. The role of insulin in the vascular contributions to age-related dementia. Biochim Biophys Acta. Forthcoming 2015. doi:10.1016/j.bbadis.2015.11.013.
  • de Bruijn RF, Portegies ML, Leening MJ, et al. Subclinical cardiac dysfunction increases the risk of stroke and dementia: the rotterdam study. Neurology. 2015;84:833–840.
  • Rasmussen P, Brassard P, Adser H, et al. Evidence for a release of brain-derived neurotrophic factor from the brain during exercise. Exposure Physiol. 2009;94:1062–1069.
  • Hollingworth P, Harold D, Sims R, et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease. Nat Genet. 2011;43:429–435.
  • Goudsmit J. The incubation period of Alzheimer’s disease and the timing of tau versus amyloid misfolding and spreading within the brain. Eur J Epidemiol. 2016;31:99–105.
  • Gerdes LU. The common polymorphism of apolipoprotein E: geographical aspects and new pathophysiological relations. Clin Chem Lab Med. 2003;41:628–631.
  • Lemogoum D, Ngatchou W, Janssen C, et al. Effects of hunter-gatherer subsistence mode on arterial distensibility in Cameroonian pygmies. Hypertension. 2012;60:123–128.
  • Assareh A, Mather KA, Schofield PR, et al. The genetics of white matter lesions. CNS Neurosci Ther. 2011;17:525–540.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.